Of course you can always land another big Pharma after leaving Novartis but not so much if you want a start up or a high end specialTy or rare disease company. That hill is a much steeper climb no doubt.
You speaking from personal experience or just giving the cheap talk of hypothetical situation? If it’s real time data that you have, let us know how it worked out for you. Otherwise save the BS talk.